Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: prostate  cancer  diagnosis  hybridyne  technologies  proxiscan  frost  sullivan  award  compact  detector  multivu  47727  lung  cancer  screening  legacy  genetech  smokers  risk  mortality  killer  smoking  life  multivu  47244  edap  tms  sa  prostate  cancer  ablatherm  hifu  treatment  high  intensity  focused  ultrasound  multivu  49862  provenge  dendreon  prostate  cancer  autologous  cellular  immunotherapy  asymptomatic  treatment  mcrpc  health  multivu  50924  nfl  football  national  prostate  cancer  awareness  month  health  aua  know  your  stats  multivu  51874  progensa  pca3  assay  molecular  test  prostate  cancer  repeat  biopsies  genprobe  fda  healthcare  multivu  53530  masturbating  nfl  urology  care  foundation  prostate  cancer  mike  haynes  harry  carson  roger  goodell  cris  carter  men  health  multivu  63352  prostate  massager  adenocarcinoma  appendix  cancer  patients  health  immunotherapy  dendritic  cell  vaccine  multivu  64654  college  american  pathologists  meeting  2014  cap14  cancer  molecular  genetic  testing  pathology  medicine  multivu  7270051  mens  health  network  joe  torre  prostate  cancer  awareness  multivu  7322251 
Search // prostate
Results 1-12 of 23 for ' prostate ' (0 seconds)
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Categories // News and Politics 
Added: 4936 days ago by MultiVuVideo
Runtime: 3m32s | Views: 6847 | Comments: 0
Not yet rated
 

 

 

With the kick-off of pro football season and September marking National Prostate Cancer Awareness Month, the American Urological Association (AUA) Foundation and the National Football League (NFL) have teamed up for a third year to educate men about prostate health and encourage them to join the “Know Your Stats” campaign. With the support of an increasing number of NFL greats and prostate cancer survivors, the national campaign is focused on turning awareness into action by encouraging men to know their risks and get tested. To view Multimedia News Release, go to http://www.multivu.com/mnr/51874-aua-foundation-nfl-mike-haynes-know-your-stats-prostate-cancer-awareness
Categories // People and Blog 
Added: 4782 days ago by MultiVuVideos
Runtime: 0m30s | Views: 6562 | Comments: 0
Not yet rated
 

 

 

Experience prostate-centered orgasms with this flexible silicone massager! Its contoured head is shaped to slide in comfortably when lubed and stays right where you need it. A perfectly placed textured nub also stimulates perineum for added sensations. Just press the button and powerful vibrations for deep orgasms! Finally, the perfectly sized prostate vibe in the perfectly safe material. Its round head always hits the spot and the flexible body that is ideally shaped to surround the perineum with gentle vibration. Powerful waterproof bullet included. Truly the best among prostate massagers.
Tags // prostate  massager 
Categories // Sexy 
Added: 4173 days ago by AdamAndEveAsS
Runtime: 2m16s | Views: 998 | Comments: 2
Not yet rated
 

 

 

In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan. “For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.” To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Categories // Miscellaneous 
Added: 3710 days ago by MultiVuVideos
Runtime: 1m0s | Views: 1145 | Comments: 0
Not yet rated
 

 

 

The Prostate Cancer Foundation is throwing a one-two punch to knock out prostate cancer for good with the recent production of a public service announcement featuring boxing legend and five-time heavyweight champion of the world Evander Holyfield. The message encourages African-American men to get regularly checked for prostate cancer because they are more than twice as likely to develop this disease than any other type of cancer. To view the Multimedia News Release, go http://www.multivu.com/players/English/7545851-pcf-holyfield-prostate-cancer-psa/
Categories // People and Blog 
Added: 3445 days ago by MultiVuVideos
Runtime: 0m55s | Views: 863 | Comments: 2
Not yet rated
 

 

 

To help officially launch Prostate Cancer Awareness Month, the Prostate Cancer Foundation (PCF) has released a new public service announcement featuring Emmy® Award-winning sports anchor and prostate cancer survivor, Brian Custer. This survivor story aims to raise awareness about the importance of prostate cancer screening among African-American men by delivering a simple message: Man Up and Get Checked. “As men, we have this ego…we think we’re too macho to go to the doctor and undergo this type of check-up,” said Custer, who hosts Showtime Championship Boxing. “But the truth is: If you don’t get checked, you’re cheating your family out of having a husband or father around. And you’re cheating yourself out of life. I hope when people hear my story, they’re motivated to take action by saying: ‘I’m going to get checked, I’m going to make sure my dad or husband gets checked, too.’” To view the multimedia release go to: http://www.multivu.com/players/English/7598151-prostate-cancer-foundation-brian-custer/
Categories // Miscellaneous 
Added: 3368 days ago by MultiVuVideos
Runtime: 2m6s | Views: 929 | Comments: 0
Not yet rated
 

 

 

With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign. The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them. “It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.” Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease. To view the multimedia release go to: http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/
Categories // Miscellaneous 
Added: 3360 days ago by MultiVuVideos
Runtime: 0m37s | Views: 871 | Comments: 0
Not yet rated
 

 

 

You Can Get The Full FREE Info Now - https://bit.ly/3stNQ4z​ Watch Video Here - https://bit.ly/3tXCgis​ Hello, I'm Dr Khatri As always, helping you stay loved, stay healthy and stay wealthy.. Today we are talking about the #1 method to help support a healthy prostate. Since numerous long stretches of individual preliminaries and tests, I accept that they have at last found an uncommon mix of fixings which may help anybody support a healthy prostate. The accompanying equation is determined and acclimated to give THE BEST POSSIBLE RESULTS with regards to help keeping up the great wellbeing of your enlarged prostate. https://www.youtube.com/watch?v=d5lwVizFwl8
Tags // prostate  health 
Categories // Miscellaneous 
Added: 1332 days ago by johngeltkn
Runtime: 3m34s | Views: 620 | Comments: 1
Not yet rated
 

 

 

Based on its recent analysis of the prostate cancer diagnosis market, Frost & Sullivan recognizes Hybridyne Technologies, Inc. with the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/47727/
Categories // News and Politics 
Added: 5054 days ago by MultiVuVideos
Runtime: 4m48s | Views: 8807 | Comments: 0
Not yet rated
 

 

 

Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer (mCRPC). To view Multimedia News Release, go to http://www.multivu.com/mnr/50924-dendreon-provenge-cellular-immunotherapy
Categories // Business 
Added: 4886 days ago by MultiVuVideos
Runtime: 3m36s | Views: 9897 | Comments: 1
Not yet rated
 

 

 

Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy. To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
Categories // News and Politics 
Added: 4662 days ago by MultiVuVideo
Runtime: 2m41s | Views: 6821 | Comments: 0
Not yet rated
 

 

 

With September marking the kickoff of the pro-football season and National Prostate Cancer Awareness Month, the Urology Care Foundation and the National Football League (NFL) teamed up to release a new Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to join the Know Your Stats® campaign. To view Multimedia News Release, go to http://www.multivu.com/mnr/63352-nfl-and-urology-care-foundation-national-prostate-cancer-awareness-month
Categories // People and Blog  Sport 
Added: 4067 days ago by MultiVuVideos
Runtime: 0m30s | Views: 2301 | Comments: 2
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.